A Randomized Pilot Trial Comparing Position Emission Tomography (PET)-Guided Dose Escalation Radiotherapy to Conventional Radiotherapy in Chemoradiotherapy Treatment of Locally Advanced Nasopharyngeal Carcinoma
Jianshe Wang(Xuzhou Medical College), Longzhen Zhang(Xuzhou Medical College), Yuanhu Yao(Xuzhou Medical College), Tianyou Tang(Xuzhou Medical College), Jing Xu(Scuola Internazionale Superiore di Studi Avanzati), Feng Zhu(Wannan Medical College), Junnian Zheng(Xuzhou Medical College), Andrew Z. Wang(Ocean NanoTech (United States))
Cited by 44
Related Papers
Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study
|Journal of Clinical Oncology|2022|306
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
|The Lancet|2021|234
HSA Coated Iron Oxide Nanoparticles as Drug Delivery Vehicles for Cancer Therapy
|Molecular Pharmaceutics|2011|219
Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment
|Oncotarget|2018|217
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
|Cancer Letters|2014|189